Socioeconomic deprivation and survival outcomes in primary central nervous system lymphomas

被引:9
|
作者
Deng, Xiangyang [1 ]
Yang, Xionggang [2 ]
Yang, Chunlei [1 ]
Chen, Kezhu [1 ]
Ren, Junwei [1 ]
Zeng, Jun [1 ]
Zhang, Quan [1 ]
Li, Tianwen [1 ]
Tang, Qisheng [1 ]
Zhu, Jianhong [1 ]
机构
[1] Fudan Univ, Huashan Hosp, Inst Brain Sci, Inst Neurosurg,Dept Neurosurg,Shanghai Med Coll,Na, Shanghai, Peoples R China
[2] Fudan Univ, Dept Orthopaed Surg, Huashan Hosp, Shanghai, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词
socioeconomic deprivation; primary central nervous system lymphoma; SEER; overall survival (OS); cancer-specific survival; PRIMARY CNS LYMPHOMA; ELDERLY-PATIENTS; UNITED-STATES; NEIGHBORHOOD; RACE/ETHNICITY; DISADVANTAGE; DISPARITIES; DIAGNOSIS;
D O I
10.3389/fonc.2022.929585
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveTo our knowledge, the impact of area-level socioeconomic status (SES) has not yet been described in primary central nervous system lymphomas (PCNSLs). Current study sought to explore the association of socioeconomic deprivation, measured using the Area Deprivation Index (ADI), with PCNSL outcomes. MethodsThe Surveillance, Epidemiology, and End Results (SEER) database was used to identify PCNSL patients diagnosed between 2006 and 2015 for our analyses. The impact of ADI on overall survival (OS) and cancer-specific survival (CSS) were investigated. Survival analyses were conducted using Kaplan-Meier method with log-rank tests. The Inverse Probability Weighting (IPW) analysis and multivariate cox proportional hazards regression analysis were employed to make covariate adjustments. Multiple mediation analysis (MMA) was performed to estimate the mediating effects. ResultsA total of 3159 PCNSL patients classified into low and high ADI subgroups according to the median ADI score were studied. The Kaplan-Meier analyses showed that low ADI was significantly associated with higher OS rates (HR 1.15, 95%CI 1.06-1.26, P<0.01) and CSS rates (HR 1.15, 95%CI 1.05-1.27, P<0.01). Similar results were observed in analyses adjusted via IPW and multivariate cox methods. Subgroup analyses revealed that ADI could remain a prognostic indictor among different subsets. MMA revealed that several factors including chemotherapy and HIV status making up about 40% of the overall effect, mediated PCNSL survival disparities related to the ADI. Finally, multivariable logistic regression analysis showed that ADI as well as several other factors were independently related to receipt of chemotherapy. ConclusionsOur study highlights the role of area-level SES in prognosis of PCNSLs. And several factors including chemotherapy and HIV status of PCNSL patents contributed to the CSS disparities between ADI subgroups were uncovered by MMA. Such relationships would highlight the importance of policies development to enhance healthcare delivery and promote awareness of HIV prevention and treatment in low-resource neighborhoods.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Impact of Postoperative Chemotherapy on Survival in Patients with Primary Central Nervous System Lymphoma: A Study Based on the SEER Database
    Chen, Yushan
    Zheng, Shuishun
    Zheng, Shunyong
    Lin, Hong
    Wei, Lizhen
    Chen, Shaoqiang
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2024, 85 (09)
  • [32] B cell clonality of primary central nervous system and primary intraocular lymphomas
    Ohta, Kouichi
    Sano, Kenji
    Suzuki, Takefumi
    Hidaka, Eiko
    Yoshida, Akiko
    Kikuchi, Takanobu
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2007, 51 (02) : 147 - 149
  • [33] Central nervous system lymphomas-Assessment and treatment and prevention of central nervous system relapse
    Ghione, Paola
    Lewis, Katharine L.
    Bobillo, Sabela
    Nayak, Laksmi
    Schorb, Elisabeth
    Nichielli, Lucia
    Ng, Andrea
    Savage, Kerry J.
    McKay, Pam
    Nastoupil, Loretta
    Soussain, Carole
    Cwynarski, Kate
    HEMATOLOGICAL ONCOLOGY, 2024, 42 (06)
  • [34] Comparative Molecular Analysis of Primary Central Nervous System Lymphomas and Matched Vitreoretinal Lymphomas by Vitreous Liquid Biopsy
    Balikov, Daniel A.
    Hu, Kevin
    Liu, Chia-Jen
    Betz, Bryan L.
    Chinnaiyan, Arul M.
    Devisetty, Laxmi V.
    Venneti, Sriram
    Tomlins, Scott A.
    Cani, Andi K.
    Rao, Rajesh C.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (18)
  • [35] Survival outcomes and treatment experience of 124 patients with primary central nervous system lymphoma
    Tang, Ziqing
    Wu, Geting
    Tan, Fang
    Long, Yang
    Hong, Jidong
    Lyu, Zhiping
    Wei, Rui
    STRAHLENTHERAPIE UND ONKOLOGIE, 2024, 200 (09) : 760 - 773
  • [36] Trends in primary central nervous system lymphoma incidence and survival in the US
    Shiels, Meredith S.
    Pfeiffer, Ruth M.
    Besson, Caroline
    Clarke, Christina A.
    Morton, Lindsay M.
    Nogueira, Leticia
    Pawlish, Karen
    Yanik, Elizabeth L.
    Suneja, Gita
    Engels, Eric A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 174 (03) : 417 - 424
  • [37] Relevance of intraocular involvement in the management of primary central nervous system lymphomas
    Ferreri, AJM
    Blay, JY
    Reni, M
    Pasini, F
    Gubkin, A
    Tirelli, U
    Calderoni, A
    Zucca, E
    Cortelazzo, S
    Chassagne, C
    Tinguely, M
    Borisch, B
    Berger, F
    Ponzoni, M
    Cavalli, F
    ANNALS OF ONCOLOGY, 2002, 13 (04) : 531 - 538
  • [38] Therapeutic management of refractory or relapsed primary central nervous system lymphomas
    Reni, M
    Ferreri, AJM
    ANNALS OF HEMATOLOGY, 2001, 80 : B113 - B117
  • [39] Primary Central Nervous System Lymphomas: A Single-center Experience
    Ozkan, Sidika Gulkan
    Safaei, Seyedehtina
    Kimiaei, Ali
    Durak, Zeynep Asli
    Yildiz, Mehmet Serdar
    Ozturkmen, Asli Yuksel
    Ozkan, Hasan Atilla
    MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL, 2025, 59 (01): : 98 - 105
  • [40] Tumor and Cerebrospinal Fluid microRNAs in Primary Central Nervous System Lymphomas
    Zajdel, Michalina
    Rymkiewicz, Grzegorz
    Sromek, Maria
    Cieslikowska, Maria
    Swoboda, Pawel
    Kulinczak, Mariusz
    Goryca, Krzysztof
    Bystydzienski, Zbigniew
    Blachnio, Katarzyna
    Ostrowska, Beata
    Borysiuk, Anita
    Druzd-Sitek, Agnieszka
    Walewski, Jan
    Chechlinska, Magdalena
    Siwicki, Jan Konrad
    CANCERS, 2019, 11 (11)